Murali Venkata Krishna Sistla
About Murali Venkata Krishna Sistla
Data last updated:
Murali Venkata Krishna Sistla has 22 years in corporate governance. Holds Director role. Currently with 4 companies, including Pharma-Serv Healthcare Private Limited and Pharma Serv Ventures Private Limited. Formerly with 5 companies, such as Enaltec Labs Private Limited and Stantech Pharmaceuticals Private Limited. Engaged in Healthcare, General Business and more. The 4 current companies with reported revenue have a combined latest revenue of ₹61.47 Cr; the largest is Nutragenix Healthcare Private Limited at ₹28.32 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nutragenix Healthcare Private Limited U74999MH2017PTC292921 | Director | 11 May 2017 | 2017 | ₹28.32 Cr (FY 2025) | Active |
 Lavue Pharmaceuticals Private Limited U74900MH2009PTC196131 | Director | 21 Dec 2009 | 2009 | ₹20.77 Cr (FY 2025) | Active |
 Pharma-Serv Healthcare Private Limited U24230MH2004PTC146489 | Director | 24 May 2004 | 2004 | ₹11.72 Cr (FY 2025) | Active |
| Pharma Serv Ventures Private Limited U24233MH2007PTC171203 | Director | 07 Nov 2008 | 2007 | ₹67 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Enaltec Labs Private Limited U21001MH2006PTC160020 | Director | 24 Feb 2006 | 2006 | ₹170 Cr (FY 2025) | Active |
 Stantech Pharmaceuticals Private Limited U24230MH2005PTC153516 | Director | 01 Oct 2012 | 2005 | ₹28.91 Cr (FY 2024) | Active |
 Eris M. J. Biopharm Private Limited U51397GJ2002PTC112851 | Director | 02 Feb 2015 | 2002 | ₹71.10 Cr (FY 2025) | Active |
 Acumedica Lab Systems Private Limited U74120MH2013PTC240805 | Director | 01 Mar 2013 | 2013 | ₹3.38 Cr (FY 2025) | Active |
| Nutragenix Biolabs Private Limited U74999MH2017PTC292897 | Director | 23 Mar 2017 | 2017 | – | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Murali Venkata Krishna Sistla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Murali Venkata Krishna Sistla
Murali Venkata Krishna Sistla has 22 years in corporate governance. Holds Director role. Currently with 4 companies, including Pharma-Serv Healthcare Private Limited and Pharma Serv Ventures Private Limited. Formerly with 5 companies, such as Enaltec Labs Private Limited and Stantech Pharmaceuticals Private Limited. Engaged in Healthcare, General Business and more. The 4 current companies with reported revenue have a combined latest revenue of ₹61.47 Cr; the largest is Nutragenix Healthcare Private Limited at ₹28.32 Cr (FY 2025).
Murali Venkata Krishna Sistla is associated with 4 companies as Director, including Nutragenix Healthcare Private Limited (₹28.32 Cr), Lavue Pharmaceuticals Private Limited (₹20.77 Cr), Pharma-Serv Healthcare Private Limited (₹11.72 Cr).
Murali Venkata Krishna Sistla has expertise in Healthcare, General Business and other sectors.
Murali Venkata Krishna Sistla has 22 years in corporate governance.
By reported revenue, the largest current company of Murali Venkata Krishna Sistla is Nutragenix Healthcare Private Limited, with revenue of ₹28.32 Cr (FY 2025).
The 4 current companies of Murali Venkata Krishna Sistla that report revenue have a combined latest revenue of ₹61.47 Cr.
Murali Venkata Krishna Sistla currently holds positions at 4 companies: Nutragenix Healthcare Private Limited (₹28.32 Cr), Lavue Pharmaceuticals Private Limited (₹20.77 Cr), Pharma-Serv Healthcare Private Limited (₹11.72 Cr), Pharma Serv Ventures Private Limited (₹67 Lakh).